Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| JAM2 | P57087 | Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322) | 1 | Fusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Multiple myelomaMyelopathy | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| LAT | O43561 | Linker for activation of T-cells family member 1 (36 kDa phosphotyrosine adapter protein) (pp36) (p36-38) | Disease related genesHuman disease related genesPlasma proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | |||
| MIEN1 | Q9BRT3 | Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35) | Predicted intracellular proteins | Other mediation | 6 | 0.63 | ||||
| MMP15 | P51511 | Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2) | Cancer-related genesEnzymesPlasma proteins | 1 | Other mediation | 6 | 0.63 | |||
| NTR1 | P30989 | Neurotensin receptor type 1 (NT-R-1) (NTR1) (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH) | 7 | Acute/chronic painDissociative neurological symptom disorderIndeterminate colitis | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.63 | |||
| PCDGA | Q9Y5H3 | Protocadherin gamma-A10 (PCDH-gamma-A10) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 6 | 0.63 | |||
| PHAG1 | Q9NWQ8 | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp) | Predicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| PHLB2 | Q86SQ0 | Pleckstrin homology-like domain family B member 2 (Protein LL5-beta) | Predicted intracellular proteinsPredicted membrane proteins | Adhesion and uptake mediationFusion and delivery mediation | 6 | 0.63 | ||||
| PKD2 | Q13563 | Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2) | Disease related genesHuman disease related genesPlasma proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 6 | 0.63 | |||
| RTN4R | Q9BZR6 | Reticulon-4 receptor (Nogo receptor) (NgR) (Nogo-66 receptor) | Fusion and delivery mediationReceptor-signaling mediation | 6 | 0.63 | |||||
| SL9A1 | P19634 | Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 13 | Angina pectorisCardiac arrhythmiaGenetic cardiac arrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4) | Disease related genesHuman disease related genesPotential drug targets | 6 | Fusion and delivery mediationImmune mediationMetabolism mediation | 6 | 0.63 | |||
| ELAF | P19957 | Elafin (Elastase-specific inhibitor) (ESI) (Peptidase inhibitor 3) (PI-3) (Protease inhibitor WAP3) (Skin-derived antileukoproteinase) (SKALP) (WAP four-disulfide core domain protein 14) | Plasma proteinsPredicted secreted proteins | Immune mediation | 20 | 0.60 | ||||
| TGFB1 | P01137 | Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)] | Human disease related genesPredicted secreted proteins | Arterial occlusive diseaseBrain cancerIdiopathic interstitial pneumonitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 20 | 0.60 | |||
| KLC1 | Q07866 | Kinesin light chain 1 (KLC 1) | Predicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 18 | 0.60 | ||||
| LPP | Q93052 | Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediation | 18 | 0.60 | ||||
| LRRF2 | Q9Y608 | Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2) | Predicted intracellular proteinsTranscription factors | Receptor-signaling mediation | 18 | 0.60 | ||||
| MAT2B | Q9NZL9 | Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase) | Metabolic proteinsPredicted intracellular proteins | Metabolism mediation | 18 | 0.60 | ||||
| PDLI5 | Q96HC4 | PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | Fusion and delivery mediation | 18 | 0.60 | ||||
| S10AE | Q9HCY8 | Protein S100-A14 (S100 calcium-binding protein A14) (S114) | Plasma proteinsPredicted intracellular proteins | Immune mediationMetabolism mediation | 18 | 0.60 | ||||
| ICAM3 | P32942 | Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Immune mediation | 17 | 0.60 | |||
| SEPT3 | Q9UH03 | Neuronal-specific septin-3 | Predicted intracellular proteins | Fusion and delivery mediation | 17 | 0.60 | ||||
| NOTC2 | Q04721 | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Lung cancerPancreatic cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 16 | 0.60 | ||
| MP2K1 | Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) | Cancer-related genesDisease related genesEnzymes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 15 | 0.60 |